Marcel Borgers

Corporate Officer/Principal bei Université Libre de Bruxelles

84 Jahre

Consumer Services

Health Technology

Aktive Positionen von Marcel Borgers

Unternehmen	Position	Beginn	Ende
Université Libre de Bruxelles	Corporate Officer/Principal	01.01.1994	-
Maastricht University	Corporate Officer/Principal	01.01.1991	-

Unternehmen	Position	Beginn	Ende
University of Antwerp	Corporate Officer/Principal	01.01.1992	01.01.2002
The Janssen Research Foundation	Corporate Officer/Principal	01.09.1969	01.04.2000
Barrier Therapeutics, Inc. Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ	Technik-/Wissenschafts-/F&E-Leiter	-	-

Université Paris 1 Panthéon-Sorbonne

Doctorate Degree

International

Operativ

Corporate Officer/Principal	4
Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Sektoral

Consumer Services	5
Health Technology	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	2
Barrier Therapeutics, Inc. Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ	Health Technology
The Janssen Research Foundation

Private Unternehmen

Health Technology

The Janssen Research Foundation